Intravitreal Gene Therapy With 4D-150: Advancing Clinical Evidence of a Potential Backbone Therapy in nAMD and DME

VIECON | Schubert Room 1 - 3

Messeplatz 1, 1020 Vienna, Austria

Saturday, 3 October 2026 | 10:15 AM - 11:15 AM CEST

Join us live in Vienna to hear leading experts discuss the future of retinal gene therapy.

Space is limited. Reserve your seat today.

_{4D-150 is an investigational gene therapy and has not been approved by health regulatory agencies.}